Pfizer less effective in S African variant: Israel

Published April 11, 2021 3,118 Views

Rumble A real-world study out of Israel suggested that the South African variant of COVID-19 could possibly 'break through' Pfizer/BioNTech's vaccine, though researchers cautioned that the sample size was small owing to its rarity in the country, and that the study had also not been peer-reviewed. Jayson Albano reports.